CMAR_A_262007 9563..9575

1Department of Pathology, Jiangxi Cancer Hospital, Nanchang, Jiangxi 330029, People’s Republic of China; 2Department of Gastrointestinal Medical Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi 330029, People’s Republic of China Background: Numerous circular RNAs (circRNAs) are functionally investigated in various human cancers, including colorectal cancer (CRC). In this study, we explored the function of circCSNK1G1 and mechanism of action in CRC, aiming to provide evidence for circCSNK1G1 involving in CRC pathogenesis. Methods: The expression of circCSNK1G1, miR-455-3p and Myosin VI (MYO6) were examined using quantitative real-time polymerase chain reaction (qRT-PCR). The functions of circCSNK1G1 on cell proliferation, apoptosis, cycle and migration/invasion were investigated using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay, colony formation assay, flow cytometry assay and transwell assay, respectively. The targeted relationship between miR-455-3p and circCSNK1G1 or MYO6 predicted by bioinformatics analysis was validated using dual-luciferase reporter assay and RNA pull-down assay. The role of circCSNK1G1 was also explored in nude mice in vivo. Results: The expression of circCSNK1G1 and MYO6 was elevated, while the expression of miR-455-3p was declined in CRC tissues and cells. Silencing circCSNK1G1 inhibited CRC cell proliferation, migration and invasion and induced cell apoptosis and cell cycle arrest. MiR-455-3p was a target of circCSNK1G1, and miR-455-3p could bind to MYO6. CircCSNK1G1 positively regulated MYO6 expression by targeting miR-455-3p. Inhibition of miR-455-3p reversed the effects of circCSNK1G1 silencing in CRC cells. Besides, miR455-3p restoration blocked CRC cell growth and metastasis, which were abolished by MYO6 overexpression. Moreover, circCSNK1G1 regulated the miR-455-3p/MYO6 axis to block tumor growth in vivo. Conclusion: CircCSNK1G1 participated in the progression of CRC partly by modulating the miR-455-3p/MYO6 network, which provided a theoretical basis for circCSNK1G1 involving in CRC pathogenesis, hinting that circCSNK1G1 might be a useful biomarker for CRC treatment.

[1]  Y. Ba,et al.  Exosome‐delivered circRNA promotes glycolysis to induce chemoresistance through the miR‐122‐PKM2 axis in colorectal cancer , 2020, Molecular oncology.

[2]  Yi Hao,et al.  Circulating lncRNA UCA1 Promotes Malignancy of Colorectal Cancer via the miR-143/MYO6 Axis , 2019, Molecular therapy. Nucleic acids.

[3]  N. Lin,et al.  Circ_0001955 facilitates hepatocellular carcinoma (HCC) tumorigenesis by sponging miR-516a-5p to release TRAF6 and MAPK11 , 2019, Cell Death & Disease.

[4]  Fei Liu,et al.  Hsa_circ_101555 functions as a competing endogenous RNA of miR-597-5p to promote colorectal cancer progression , 2019, Oncogene.

[5]  Xiaoping Yang,et al.  Circular RNA hsa_circRNA_102958 promotes tumorigenesis of colorectal cancer via miR-585/CDC25B axis , 2019, Cancer management and research.

[6]  S. Dhanasekaran,et al.  The Landscape of Circular RNA in Cancer , 2019, Cell.

[7]  L. Feuk,et al.  Expression profiling and in situ screening of circular RNAs in human tissues , 2018, Scientific Reports.

[8]  J. Li,et al.  Upregulated miR‐1258 regulates cell cycle and inhibits cell proliferation by directly targeting E2F8 in CRC , 2018, Cell proliferation.

[9]  W. Ng,et al.  Functional role of circular RNAs in cancer development and progression , 2018, RNA biology.

[10]  Junjie Xiao,et al.  Circular RNAs: Promising Biomarkers for Human Diseases , 2018, EBioMedicine.

[11]  R. Xiang,et al.  Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer , 2018, PloS one.

[12]  K. To,et al.  MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside , 2018, World journal of gastroenterology.

[13]  W. Yuan,et al.  MiR-760 suppresses human colorectal cancer growth by targeting BATF3/AP-1/cyclinD1 signaling , 2018, Journal of experimental & clinical cancer research : CR.

[14]  U. Testa,et al.  Colorectal Cancer: Genetic Abnormalities, Tumor Progression, Tumor Heterogeneity, Clonal Evolution and Tumor-Initiating Cells , 2018, Medical sciences.

[15]  B. Han,et al.  Circular RNA and its mechanisms in disease: From the bench to the clinic. , 2018, Pharmacology & therapeutics.

[16]  Yan Wang,et al.  miR-455-3p functions as a tumor suppressor in colorectal cancer and inhibits cell proliferation by targeting TPT1. , 2018, International journal of clinical and experimental pathology.

[17]  Zhigang Wang,et al.  Downregulation of myosin VI reduced cell growth and increased apoptosis in human colorectal cancer. , 2018, Acta biochimica et biophysica Sinica.

[18]  Xiaohui Wang,et al.  miR-455-3p serves as prognostic factor and regulates the proliferation and migration of non-small cell lung cancer through targeting HOXB5. , 2018, Biochemical and biophysical research communications.

[19]  AN Wei,et al.  Long non-coding RNA SOX21-AS1 sponges miR-145 to promote the tumorigenesis of colorectal cancer by targeting MYO6. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[20]  L. Holdt,et al.  Molecular roles and function of circular RNAs in eukaryotic cells , 2017, Cellular and Molecular Life Sciences.

[21]  Libing Song,et al.  Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma , 2017, Molecular Cancer.

[22]  Elena Cerrada,et al.  Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer , 2017, International journal of molecular sciences.

[23]  Hui Chen,et al.  MicroRNA-455-3p Inhibits Tumor Cell Proliferation and Induces Apoptosis in HCT116 Human Colon Cancer Cells , 2016, Medical science monitor : international medical journal of experimental and clinical research.

[24]  Ping Zhong,et al.  Myosin VI contributes to malignant proliferation of human glioma cells , 2016, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

[25]  William M. Grady,et al.  Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers. , 2015, Gastroenterology.

[26]  Jiang-xia Zhao,et al.  Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis , 2015, Cell Research.

[27]  Li Yang,et al.  Regulation of circRNA biogenesis , 2015, RNA biology.

[28]  M. Fabbri,et al.  MicroRNAs and other non-coding RNAs as targets for anticancer drug development , 2013, Nature Reviews Drug Discovery.

[29]  H. Samonigg,et al.  Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer , 2012, British Journal of Cancer.

[30]  P. Maisonneuve,et al.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. , 2008, Gastroenterology.

[31]  B. Levin,et al.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. , 2008, Gastroenterology.

[32]  F. Buss,et al.  How are the cellular functions of myosin VI regulated within the cell? , 2008, Biochemical and biophysical research communications.

[33]  J. Mattick,et al.  Non-coding RNA. , 2006, Human molecular genetics.

[34]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[35]  R. Houlston,et al.  A systematic review and meta-analysis of familial colorectal cancer risk , 2001, American Journal of Gastroenterology.

[36]  K. Abrams,et al.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis , 2001, Gut.

[37]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.